Seth Baum M.D., MASPC, FACC, FAHA, FNLA shares what the availability of a new treatment means to the FCS community. Learn more: https://lnkd.in/eg2G4NpH
Ionis Pharmaceuticals, Inc.’s Post
More Relevant Posts
-
Registration for today's webinar with Prof. Dan Dewey from Brigham Young University is closing soon. Learn about the vast potential of fNIRS outside traditional lab settings, its adaptability to various environments, and solutions to challenges like Wi-Fi interference. Join us for insights on real-time data collection with fNIRS in valid settings. Don't miss out! #fNIRS #Webinar
To view or add a comment, sign in
-
Attend our upcoming online webinar with Prof. Dan Dewey from Brigham Young University. Discover the extensive potential of fNIRS beyond labs, excelling in natural environments and overcoming challenges like Wi-Fi interference and limited electricity. Learn about its benefits such as portability, non-invasiveness, and wide applicability including real-time data collection in true-to-life situations. #fNIRS #ResearchInnovation
To view or add a comment, sign in
-
Check out my blog post https://wix.to/hUCQVv0 #Perseverance: the Secret of all triumphs. True for everything, but described for GDD and chelation here.
To view or add a comment, sign in
-
Using a novel multidimensional approach to ACS TQIP data, we identified the highest-performing level I and II trauma centers in the United States. We showed improved discriminatory ability and found significant differences in performance and structural factors between centers. https://lnkd.in/gpJ5Uc56
To view or add a comment, sign in
-
Using a novel multidimensional approach to ACS TQIP data, we identified the highest-performing level I and II trauma centers in the United States. We showed improved discriminatory ability and found significant differences in performance and structural factors between centers. https://lnkd.in/gpJ5Uc56
To view or add a comment, sign in
-
In our eighth State AG Pulse episode in season 4, we discuss the primary outcome in West Virginia as well as the remaining state AG primaries in Utah, Missouri, and Vermont. Chris Allen, Katen Bhirud, and Emily Yu of Cozen O'Connor then delve into the topic of federalism, the increasingly active role state AGs are taking when it comes to federal regulation, and how businesses can engage strategically with AGs to ensure their voices are heard.
State AG Pulse | The State AG: Both Advocate & Influencer
To view or add a comment, sign in
-
Our *NEW* resource guide, developed in collaboration with the CSN-A, provides Title V agencies with information on nationally focused #publichealth organizations that work to advance #childsafety. Discover potential collaborators: go.edc.org/Partners #prevention
To view or add a comment, sign in
-
Using a novel multidimensional approach to ACS TQIP data, we identified the highest-performing level I and II trauma centers in the United States. We showed improved discriminatory ability and found significant differences in performance and structural factors between centers. https://lnkd.in/gpJ5Uc56
To view or add a comment, sign in
-
Witness our R&D in action – it's beyond belief https://lnkd.in/gPmjQ3q6
To view or add a comment, sign in
-
Want to learn more about #bowentheory? Check out our March edition of Bowen Bites and click below for more information about The KC Center for Family Systems! https://lnkd.in/dY_nQFrG
To view or add a comment, sign in
72,304 followers
Executive Vice President, Drug Development at Ionis Pharmaceuticals, Inc.
6dThanks for sharing Seth. Thank you for all your support in bringing this medicine to patients!